PVMCV
LYRA

Polaris Venture Management Co V’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Polaris Venture Management Co V’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$10M Hold
22,017
– – 71.28% 1
2021
Q2 		$8.84M Hold
22,017
– – 14.16% 2
2021
Q1 		$12.8M Hold
22,017
– – 16.54% 2
2020
Q4 		$12.6M Hold
22,017
– – 16.38% 2
2020
Q3 		$12.3M Hold
22,017
– – 20.29% 2
2020
Q2 		$12.5M Buy
+22,017
New +$16.1M 9.72% 3

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Polaris Venture Management Co V's LYRA Position: Q3 2021 in Review

Polaris Venture Management Co V held its LYRA THERAPEUTICS INC (LYRA) position steady in Q3 2021 at 22,017 shares worth $10M. The position accounts for 71.28% of the portfolio, ranked #1.

Polaris Venture Management Co V first reported a position in LYRA in Q2 2020 and has held it in 6 quarters since. The position peaked at $12.8M in Q1 2021. 35 funds tracked by Wall St. Rank hold LYRA as of Q3 2021.

  • Polaris Venture Management Co V held 22,017 shares of LYRA THERAPEUTICS INC worth $10M as of Q3 2021.
  • Polaris Venture Management Co V left its LYRA THERAPEUTICS INC share count unchanged in Q3 2021.
  • LYRA THERAPEUTICS INC made up 71.28% of Polaris Venture Management Co V's portfolio in Q3 2021, its #1 holding.
  • Polaris Venture Management Co V first reported a position in LYRA THERAPEUTICS INC in Q2 2020 and has held it in 6 quarters since.
  • Polaris Venture Management Co V's LYRA THERAPEUTICS INC position peaked at $12.8M in Q1 2021.
  • 35 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q3 2021.

Based on Polaris Venture Management Co V's 13F filing for Q3 2021, filed 12 Nov 2021.